Core Insights - The article discusses the launch of a new low-priced product, "Miracle Youth 3.0," by the internet medical beauty platform New Oxygen, which has significantly reduced the price of the "youthful needle" to 2999 yuan, breaking the previous market average of over 10,000 yuan [1][2] - New Oxygen aims to disrupt the high-price cycle in the medical beauty industry and make compliant medical beauty services more accessible to consumers [1][6] - The company is facing performance pressures, with a reported 7% year-on-year decline in overall revenue and a net loss of 36 million yuan in Q2 2025 [1][4] Market Dynamics - The "youthful needle" market is rapidly expanding, with an expected B-end market size of 4.2 billion yuan by 2025, up from 500 million yuan in 2021 [2] - New Oxygen's strategy includes reducing customer acquisition costs and lowering unrelated treatment costs to maintain service quality while implementing low pricing [3][4] - The company has launched a new chain brand, "New Oxygen Youth Clinics," with 37 stores opened and plans to exceed 50 by the end of 2025 [3][4] Financial Performance - New Oxygen's offline business revenue surged by 426.1% year-on-year to 144 million yuan in Q2 2025, surpassing online business revenue for the first time [4] - Despite the growth in offline business, the overall revenue decline reflects the challenges of transitioning from traditional platform services to new business models [4][5] - The company is currently in a loss phase for its chain business but expects to reach profitability as it scales [4][5] Industry Challenges - The medical beauty industry is described as being in a "vicious cycle," where high upstream costs lead to inflated prices, pushing consumers towards unregulated options [6] - New Oxygen's CEO emphasizes the need for a shift towards lower prices to enhance consumer trust and increase market penetration [6][7] - The market is witnessing a shift towards "light medical beauty," which is expected to drive growth and lower consumer barriers [7] Competitive Landscape - Major internet companies are increasingly entering the medical beauty sector, intensifying competition [7] - New Oxygen welcomes the entry of more competitors, believing it will help develop and expand the new business model of medical beauty chains [7]

Core Viewpoint - The launch of the new "Miracle Tongyan 3.0" by Xinyang at a price of 2999 yuan marks a significant price drop in the market for Tongyan injections, which typically exceed 10,000 yuan, establishing a new low price point in the industry [1][4]. Pricing Strategy - Xinyang's pricing strategy is based on obtaining pricing authority from upstream manufacturers, allowing them to offer competitive prices [6][7]. - The previous versions of Tongyan injections were priced at 4999 yuan and 5999 yuan, indicating a trend of progressively lowering prices [4][9]. Market Context - The current market for Tongyan injections includes several high-priced products, with manufacturers like Saint Boma and Kanjie Pharmaceuticals pricing their products between 12,800 yuan and 14,800 yuan [4][9]. - The trend of decreasing prices for Tongyan injections is expected to continue, driven by market demand and product effectiveness [5]. Company Performance - Xinyang's clinics have achieved monthly profitability at the store level, although overall profitability is still pending due to the costs associated with middle and back-end operations [9]. - The company plans to expand its clinic network significantly, aiming for over 50 locations by the end of 2025, with a long-term goal of establishing a presence in 100 cities [9]. Financial Growth - Xinyang reported a substantial increase in revenue from its light medical beauty chain business, with a year-on-year growth of 551.4% in Q1 2025, reaching 98.8 million yuan [10]. - In Q2 2025, revenue from beauty treatment services also saw a significant increase of 426.1%, totaling 144.4 million yuan [10].

9月23日，互联网医美平台新氧（Nasdaq：SY，股价3.72美元，市值3.69亿美元）正式推出全新一代"奇迹童颜3.0"，将童颜针价格直接拉至2999元，创下 行业历史新低。而此前，中国内地"童颜针"的市场均价普遍在万元以上。 此次价格大幅下调的背后，是新氧试图以低价策略打破医美行业长期存在的高价"恶性循环"，通过自营连锁诊所与供应链定制，推动行业从"卖方市场"转 向"大众消费"。 在新氧创始人兼CEO（首席执行官）金星看来，低价策略也是医美困境的破局关键。他直言："如果想把中国市场里的黑医美彻底打掉，那只有让整个合 规医美的价格变得能让消费者触手可及。" 不过，《每日经济新闻》记者（以下简称"每经记者"）注意到，在这一策略推出之际，新氧正面临业绩压力。今年二季度，公司整体营收同比下降7%， 净亏损3600万元，由盈转亏。新氧CFO（首席财务官）赵晖在业绩说明会上表示，业绩下滑的主要原因是订阅平台信息服务的医疗服务提供商数量减少。 新氧创始人兼CEO金星 图片来源：每经记者 李宇彤 摄 新氧尚在投入阶段的线下连锁业务，能否承担起转型后的业绩重任？低价策略又是否能支撑其颠覆行业格局的雄心？ 每经记者｜李宇彤 ...

不过，《每日经济新闻》记者（以下简称"每经记者"）注意到，在这一策略推出之际，新氧正面临业绩压力。今年二季度，公司整体营收同比下降7%，净 亏损3600万元，由盈转亏。新氧CFO（首席财务官）赵晖在业绩说明会上表示，业绩下滑的主要原因是订阅平台信息服务的医疗服务提供商数量减少。 医美市场"价格战"开打。 9月23日，互联网医美平台新氧（Nasdaq：SY，股价3.72美元，市值3.69亿美元）正式推出全新一代"奇迹童颜3.0"，将童颜针价格直接拉至2999元，创下行 业历史新低。而此前，中国内地"童颜针"的市场均价普遍在万元以上。 此次价格大幅下调的背后，是新氧试图以低价策略打破医美行业长期存在的高价"恶性循环"，通过自营连锁诊所与供应链定制，推动行业从"卖方市场"转 向"大众消费"。 在新氧创始人兼CEO（首席执行官）金星看来，低价策略也是医美困境的破局关键。他直言："如果想把中国市场里的黑医美彻底打掉，那只有让整个合规 医美的价格变得能让消费者触手可及。" 新氧创始人兼CEO金星图片来源：每经记者 李宇彤 摄 新氧尚在投入阶段的线下连锁业务，能否承担起转型后的业绩重任？低价策略又是否能支撑其颠覆行业格局的 ...

Group 1: New Technologies and Innovations - New Stone Technology announced the delivery of its 10,000th unmanned delivery vehicle, marking the world's first fleet of this scale and indicating a significant shift from technology validation to large-scale commercialization in the unmanned delivery industry [1] - New Stone's achievement demonstrates the reliability of technology and commercial viability, significantly reducing costs through scale, providing a model for industry profitability [1] - The industry competition is currently focused on road rights and cost, with New Stone leading due to its advantages in road rights across hundreds of cities and a cost of approximately 70,000 yuan, although competitors like Momo and Jiushi have achieved lower pricing [1] Group 2: Consumer Goods and Market Trends - Luo Yonghao announced plans to evaluate pre-packaged meals available on the market, emphasizing a neutral stance by not engaging in live commerce, which could enhance consumer trust in the industry [2] - This initiative comes at a critical time for the industry, potentially pushing companies to strengthen quality control and shifting competition from price wars to brand trust [2] Group 3: Pricing Strategies in the Beauty Industry - New Oxygen launched its new product "Miracle Youth 3.0" at a price of 2,999 yuan, aiming to address high prices and rampant black market practices in the medical beauty industry [3] - The introduction of this competitively priced product targets the issue of inflated prices in the market, potentially leading to a more rational pricing system [3] - However, the low pricing strategy may trigger a price war in the industry, necessitating New Oxygen to ensure service quality while exploring sustainable business models [3] Group 4: E-commerce and Brand Expansion - Alibaba's AliExpress launched the "Super Brand Going Global Plan," aiming to achieve higher sales at half the cost of Amazon, directly challenging Amazon's dominance in the mid-to-high-end brand market [4] - In the first half of the year, AliExpress saw a 70% year-on-year increase in new brands, with over 500 brands doubling their sales and more than 2,000 brands expanding into new overseas markets [4] - This initiative signifies a shift from a focus on cost-effectiveness to targeting the mid-to-high-end market, reshaping the landscape of cross-border e-commerce and prompting a shift towards refined operations and cost control [4]

Group 1: New Technologies and Market Developments - New Stone announced the delivery of its 10,000th unmanned delivery vehicle, marking the world's first fleet of this scale and indicating a significant shift from technology validation to large-scale commercialization in the unmanned delivery industry [1] - New Stone's achievement demonstrates the reliability of technology and commercial viability, significantly reducing costs through scale, providing a model for industry profitability [1] - The competition in the industry is now focused on road rights and cost, with New Stone leading due to its advantages in road rights across hundreds of cities and a cost of around 70,000 yuan, although competitors like Momo and Jiushi have achieved lower pricing [1] Group 2: Consumer Trust and Market Competition - Luo Yonghao announced plans to evaluate pre-packaged meals available on the market, emphasizing a neutral stance by not engaging in live commerce, which could enhance consumer trust in the industry [2] - This initiative comes at a critical time for the industry, potentially pushing companies to strengthen quality control and shifting competition from price wars to brand trust [2] Group 3: Pricing Strategies in the Aesthetic Medicine Market - New Oxygen launched the "Miracle Youth Needle 3.0" at a price of 2,999 yuan, aiming to address high prices and rampant black market practices in the aesthetic medicine sector [3] - This move targets the issue of inflated prices in the market, potentially leading to a more rational pricing system, although it may also trigger price wars and increase market competition [3] Group 4: E-commerce and Brand Expansion - Alibaba's AliExpress launched the "Super Brand Going Global Plan," aiming to achieve higher sales at half the cost of Amazon, directly challenging Amazon's dominance in the mid-to-high-end brand market [4] - In the first half of the year, AliExpress saw a 70% year-on-year increase in new brands, with over 500 brands doubling their sales and more than 2,000 brands exploring new overseas markets [4] - This initiative signifies a shift from a focus on cost-effectiveness to targeting the mid-to-high-end market, reshaping the landscape of cross-border e-commerce and prompting a shift towards refined operations and cost control [4]

Core Viewpoint - New Oxygen Technology has launched the Miracle Youth Needle 3.0 at a price of 2999 yuan, marking the lowest price in the history of youth needles, aiming to make aesthetic medical treatments more affordable for consumers [1] Group 1: Product Launch and Pricing Strategy - The price of youth needles in the market typically ranges from 13,000 to 24,000 yuan, while New Oxygen's previous versions were priced at 4999 yuan and 5999 yuan, significantly lower than competitors [1] - The CEO of New Oxygen stated that high prices in the mainland market are due to high procurement costs and upstream manufacturers controlling retail prices, and the company aims to challenge the notion that the aesthetic medical industry must rely on high profits [1] Group 2: Supplier Relations and Challenges - New Oxygen faced pressure from upstream manufacturers, including legal threats, when it attempted to lower prices with its earlier versions, which led to conflicts over pricing and product authenticity [1] - The company has now partnered with Xihong Bio, which does not impose price controls, to ensure a stable supply chain and maintain quality service for consumers [2] Group 3: Business Expansion and Operational Insights - New Oxygen has opened 37 clinics since May 2023, with plans to exceed 50 by the end of 2025 and aims for a long-term goal of establishing a presence in 100 cities [2] - Currently, the clinic operations are not profitable due to the costs associated with establishing a central support system, but the individual clinics have achieved monthly profitability, indicating potential for future overall profitability [2]

童颜针"价格战"正迎来最激烈的时刻。 9月23日，新氧（SY.O）正式推出奇迹童颜3.0，定价为2999元，创下童颜针史上最低价——目前市面上 的艾维岚、塑妍萃等童颜针单价基本在1.3万元到2.4万元不等。 操作方面，新氧的奇迹童颜3.0主要采取童颜针"塑缇妍"复配玻尿酸的形式。 塑缇妍的出品方是江苏西宏生物医药有限公司（下称"西宏生物"），其母公司系正在冲刺港股IPO的东 方妍美（成都）生物技术股份有限公司。 据金星透露，1.0、2.0版本分别采用的是普丽妍（南京）医疗科技有限公司（下称"普丽妍"）的普丽 妍、长春圣博玛生物材料有限公司（下称"圣博玛"）的艾维岚，这两家厂商要求终端售价分别为16800 元/支，18800元/支，但新氧的定价分别低至4999元、5999元。 这引发了上游医美材料商的不满，普丽妍、圣博玛都先后向新氧发函，要求下架童颜针的产品。 今年7月，西宏生物的童颜针（丽真然）获批上市，其大中华区的推广、商业化等权益被授权给了康哲 药业（0867.HK）。 "塑缇妍是我们与西宏生物定制的产品，与丽真然为同款童颜针，但型号略有不同。"新氧CEO金星告诉 信风，"西宏生物不干涉下游的定价。" 短 ...